Human gene therapy - JoVE Visualize

Showing results (2591-2600 of 4,125) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|October 30, 1998

Genetic vaccination-induced immune responses to the human immunodeficiency virus protein Rev: emergence of the interleukin 2-producing helper T lymphocyteS Y Chan, M C Louie, J R Piccotti, et al.

Human Gene Therapy|October 30, 1998

Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responsesK Otake, D L Ennist, K Harrod, et al.

Human Gene Therapy|October 30, 1998

Poor expression of MDR1 transgene in HeLa cells by bicistronic Moloney murine leukemia virus-based vectorM M Zaboikin, F G Schuening

Human Gene Therapy|January 9, 2008

Lentiviral vectors mediate nonimmunosuppressive rapamycin analog-induced production of secreted therapeutic factors in the brain: regulation at the level of transcription and exocytosisRoland Vogel, Hamid Mammeri, Jacques Mallet

Human Gene Therapy|May 1, 1997

Progress in transcriptionally targeted and regulatable vectors for genetic therapyN Miller, J Whelan

Human Gene Therapy|May 1, 1997

Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectorsC A Wilson, T H Ng, A E Miller

Human Gene Therapy|May 1, 1997

Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcomaD M Mahvi, P M Sondel, N S Yang, et al.

Human Gene Therapy|October 6, 1998

Use of nonautologous microencapsulated fibroblasts in growth hormone gene therapy to improve growth of midget swineW T Cheng, B C Chen, S T Chiou, et al.

Human Gene Therapy|October 6, 1998

Anti-HIV type 1 activity of wild-type and functional defective RANTES intrakine in primary human lymphocytesA G Yang, X Zhang, F Torti, et al.

Human Gene Therapy|October 6, 1998

Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancerD S Heo, S J Yoon, W S Kim, et al.

Pageof 413

Showing results (2591-2600 of 4,125) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|October 30, 1998

Genetic vaccination-induced immune responses to the human immunodeficiency virus protein Rev: emergence of the interleukin 2-producing helper T lymphocyteS Y Chan, M C Louie, J R Piccotti, et al.

Human Gene Therapy|October 30, 1998

Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responsesK Otake, D L Ennist, K Harrod, et al.

Human Gene Therapy|October 30, 1998

Poor expression of MDR1 transgene in HeLa cells by bicistronic Moloney murine leukemia virus-based vectorM M Zaboikin, F G Schuening

Human Gene Therapy|January 9, 2008

Lentiviral vectors mediate nonimmunosuppressive rapamycin analog-induced production of secreted therapeutic factors in the brain: regulation at the level of transcription and exocytosisRoland Vogel, Hamid Mammeri, Jacques Mallet

Human Gene Therapy|May 1, 1997

Progress in transcriptionally targeted and regulatable vectors for genetic therapyN Miller, J Whelan

Human Gene Therapy|May 1, 1997

Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectorsC A Wilson, T H Ng, A E Miller

Human Gene Therapy|May 1, 1997

Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcomaD M Mahvi, P M Sondel, N S Yang, et al.

Human Gene Therapy|October 6, 1998

Use of nonautologous microencapsulated fibroblasts in growth hormone gene therapy to improve growth of midget swineW T Cheng, B C Chen, S T Chiou, et al.

Human Gene Therapy|October 6, 1998

Anti-HIV type 1 activity of wild-type and functional defective RANTES intrakine in primary human lymphocytesA G Yang, X Zhang, F Torti, et al.

Human Gene Therapy|October 6, 1998

Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancerD S Heo, S J Yoon, W S Kim, et al.

Pageof 413